Migrant Serum Bank
The Migrant Serum Bank (MSB), a serum repository, was established in 2002 to provide the opportunity to understand important public health problems that might impact migrant populations, such as vaccine-preventable diseases, intestinal parasites and other emerging infectious diseases, and non-communicable diseases. Over 500,000 immigrants and refugees who resettle to the US annually are required to undergo medical examinations that address a limited number of communicable diseases of public health importance. The MSB is composed of anonymous sera remaining from blood collected from US-bound immigrants and refugees during these exams. Additional demographic information that may be available for sera include age at collection, gender, birth city/country, country of processing, refugee group, and refugee camp (if available).
As of 2008, the MSB has obtained more than 40,000 sera from immigrants and refugees from Africa, Asia, the Middle East, and Mexico. These specimens are available for investigators once a study proposal has been approved by the Division of Global Migration and Quarantine.
For additional information on MSB and request for sera, contact us at firstname.lastname@example.org.
Selected Studies Using the Serum Bank Specimens
|Seroprevalence of Histoplamosis||Somali, Burmese, and Hmong Refugees in Thailand and Kenya||To assess the seroprevalence and risk of Histoplasma capsulatum infection in refugee groups residing in Thailand and Kenya for extended periods of time||Bahr NC, Lee D, Stauffer WM, et al. Seroprevalence of Histoplasmosis in Somali, Burmese, and Hmong Refugees Residing in Thailand and Kenya. Journal of immigrant and minority health. 2018;20(2):334-338.|
|Hepatitis B virus and hepatitis C virus infections in United States- bound refugees||Asia, Africa||To assess the prevalence of active hepatitis B and C virus infections in at-risk populations in order to describe epidemiologic and virologic characteristics||Mixson-Hayden T, Lee D, Ganova-Raeva L, et al. Hepatitis B virus and hepatitis C virus infections in United States-bound refugees from Asia and Africa. The American journal of tropical medicine and hygiene. 2014;90(6):1014-1020.|
|Seroprevalence of antibodies against Taenia solium cysticerci among refugees resettled in United States||Laos, Burma, Bhutan, Burundi||To assess the seroprevalence of antibodies against T. solium cysts to determine public health implications and future research||O’Neal SE, Townes JM, Wilkins PP, et al. Seroprevalence of antibodies against Taenia solium cysticerci among refugees resettled in United States. Emerging infectious diseases. 2012;18(3):431-438.|
|Intestinal helminth testing||Somali||To determine the seroprevalence of schistosoma and strongloides||Posey DL, et al. High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees. Clin Infect Dis. 2007 Nov 15;45(10):1310-5.|